Cooper companies executive sells over $172k in stock By Investing.com

Agostino Ricupati, the Senior Vice President and Chief Accounting Officer (SVP & CAO) of Cooper Companies, Inc. (NYSE:COO), has recently engaged in significant stock transactions, according to a new SEC filing. On a single day, Ricupati sold 1,601 shares of the company’s common stock at an average price of $108.03, netting a total of $172,955.

This sale was part of a series of transactions reported by Ricupati. On the same day as the sale, he also disposed of 1,053 shares through a transaction that involved paying an average price of $99.24 per share, which amounted to a total value of $104,499.

Investors and market watchers often look to insider buying and selling as a signal of a company’s prospects. While the reasons for an executive’s decision to sell can vary, these transactions are closely monitored for insights into both personal portfolio management and broader company health.

The reported transactions are part of Ricupati’s regular financial activities involving the stock of Cooper Companies, a global medical device company specializing in ophthalmic products. The company’s shares are traded on the New York Stock Exchange under the ticker symbol NYSE:COO.

The recent filings also corrected a previous underreporting error, adding an additional 83 shares to Ricupati’s beneficially owned securities. Moreover, the documents include footnotes indicating the acquisition of shares through the company’s Employee Stock Purchase Plan and the vesting schedule of restricted stock units (RSUs).

Cooper Companies has not provided any official comment on these transactions. However, the disclosed trades offer a glimpse into the stock dealings of one of its top executives. As with all insider transactions, these recent moves by Ricupati will be of interest to current and potential investors as they assess the company’s stock performance and insider confidence.

In other recent news, Cooper Companies has been making significant strides in its financial performance. The company recently exceeded expectations with a $5 million revenue beat and a $0.05 earnings per share beat, according to Mizuho Securities. Cooper Companies’ robust results were due to strong sales across various product segments, with Toric & Multifocal and Sphere revenue lines surpassing forecasts.

The company’s gross margin reached 66.6%, exceeding the Street’s expectation of 66.0%, and its adjusted operating margin stood at 25.5%, surpassing the anticipated 24.1%. These recent developments highlight the advantages of Cooper Companies’ product and geographic mix, as well as the effective management of selling, general, and administrative expenses.

In addition, Cooper Companies posted record-breaking third quarter revenues for 2024, surpassing $1 billion, marking an 8% increase from the previous year. The company’s CooperVision and CooperSurgical divisions both contributed to this growth with notable improvements in their margins.

Looking forward, Cooper Companies provided an adjusted earnings per share guidance of $0.98 to $1.01 for the fourth fiscal quarter of 2024, which is above the Street’s estimate of $0.96. This guidance, along with the company’s raised full-year revenue guidance, reflects the company’s continued strength and positive momentum. Mizuho Securities has subsequently increased the price target for Cooper Companies, reflecting confidence in the company’s sustained premium growth and operational leverage moving forward.

InvestingPro Insights

The recent stock transactions by Agostino Ricupati at Cooper Companies, Inc. (NYSE:COO) have coincided with a period of notable financial metrics for the company. According to InvestingPro data, Cooper Companies boasts a market capitalization of $21.56 billion, reflecting its substantial presence in the medical device industry. The company’s P/E ratio stands at a high 59.92, indicating investors’ willingness to pay a premium for its earnings, which aligns with the InvestingPro Tip that the stock is trading at a high earnings multiple. This could suggest market optimism about the company’s future growth prospects or a reflection of the stock’s perceived stability.

InvestingPro data also reveals that Cooper Companies has experienced a revenue growth of 8.25% over the last twelve months as of Q3 2024, highlighting the company’s ability to expand its sales in a competitive sector. Moreover, the company’s gross profit margin is reported at a healthy 66.36%, which is indicative of its efficient cost management and strong pricing power.

For investors considering the company’s stock, one of the InvestingPro Tips notes that 13 analysts have revised their earnings upwards for the upcoming period, suggesting a positive outlook on Cooper Companies’ financial performance. This is complemented by the fact that the company is expected to be profitable this year, as per another InvestingPro Tip. For those interested in a more comprehensive analysis, InvestingPro offers additional tips on Cooper Companies, which can be found at https://www.investing.com/pro/COO.

Lastly, with the stock trading near its 52-week high and having shown a strong return over the last month, investors might interpret Ricupati’s recent stock sale within the context of the company’s current valuation and recent price performance. These data points and insights from InvestingPro can provide a richer understanding for investors following insider transactions and assessing the company’s stock potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.